Concepedia

Yongying Jiang

YJ

37

Publications

2.5K

Citations

22

H-Index

2001

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Rutgers, The State University of New Jersey

University of California, San Francisco

Beth Israel Deaconess Medical Center

Harvard University

Yongying Jiang is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, natural sciences, and biochemistry.

ORCID

Top concepts

Publications per year

2001–2023

37

Publications

37

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Jennifer R. Molina, Yuting Sun, Marina Protopopova et al. · Nature Medicine · 2018 · 903 citations · Full text

, , +4

Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma

Ana C. deCarvalho, Hoon Kim, Laila Poisson et al. · Nature Genetics · 2018 · 311 citations · Full text

, , +11

Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib

Yuting Sun, Brooke A. Meyers, Barbara Czakó et al. · Cancer Research · 2020 · 101 citations · Full text

A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia

Lisa S. Chen, Prithviraj Bose, Nichole Cruz et al. · Blood · 2018 · 100 citations · Full text

An enolase inhibitor for the targeted treatment of ENO1-deleted cancers

Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi et al. · Nature Metabolism · 2020 · 95 citations · Full text

, , +5

Rows per page

1–5 of 37